Evidence map›Paper›PMID 38438550›Full record

ArticlePediatric research2024

Perinatal risk factors associated with acute kidney injury severity and duration among infants born extremely preterm.

Keia Sanderson, Russell Griffin, Nekayla Anderson, Andrew M South, Jonathan R Swanson, Michael Zappitelli, Heidi J Steflik, Marissa J DeFreitas, Jennifer Charlton, David Askenazi and 1 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Pediatric research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Impact of maternal health on neonatal and long-term kidney outcomes.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 20 institutions in 3 countries.

Keia SandersonUniversity of North Carolina Department of Medicine-Nephrology, Chapel Hill, NC, USA. keia_sanderson@med.unc.edu.
Russell GriffinDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Nekayla AndersonDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Andrew M SouthDepartment of Pediatrics, Section of Nephrology, Brenner Children's, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Jonathan R SwansonDivision of Neonatology, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, VA, USA.
Michael ZappitelliDepartment of Pediatrics, Division of Nephrology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Heidi J SteflikDivision of Neonatal-Perinatal Medicine, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
Marissa J DeFreitasDivision of Pediatric Nephrology, Department of Pediatrics, University of Miami, Miami, FL, USA.
Jennifer CharltonUniversity of Virginia, Department of Pediatrics, Division of Nephrology, Charlottesville, VA, USA.
David AskenaziDivision of Nephrology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
Neonatal Kidney Collaborative (NKC) Research Committee
University of Alabama at Birmingham · USMedical University of South Carolina · USUniversity of Virginia · USAkron Children's Hospital · USAlbert Einstein College of Medicine · USCincinnati Children's Hospital Medical Center · USHospital for Sick Children · CAIndiana University Health · USIndiana University – Purdue University Indianapolis · USMedical College of Wisconsin · USSt.John's Medical College Hospital · INStony Brook University · USUniversity of Cincinnati Medical Center · USUniversity of Kentucky · USUniversity of Miami · USUniversity of North Carolina at Chapel Hill · USUniversity of Rochester · USUniversity of Washington · USUniversity of Wisconsin–Madison · USWake Forest University · US

Funding

Single-Cell Epigenomics, Transcriptomics, and Bioinformatics CoreP50DK096373 · NIDDK · UNIVERSITY OF VIRGINIA · PI ROBERTO Ariel GOMEZ · 2012 to 2026
$13.8M
Preterm Epo Neuroprotection Trial (PENUT Trial) CCCU01NS077953 · NINDS · UNIVERSITY OF WASHINGTON · PI JUUL, SANDRA E · 2013 to 2018
$10.7M
Uric Acid, Klotho and Salt Sensitivity in Young Adults Born PretermR01HL146818 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CHAPPELL, MARK C, SHALTOUT, HOSSAM · 2019 to 2023
$4.0M
Institutional Career Development CoreKL2TR002737 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RUNDEK, TATJANA, SCOTT, GWENDOLYN BARBARA · 2018 to 2022
$3.6M
Recombinant Erythropoietin for Protection of Infant Renal Disease(REPAIReD)R01DK103608 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI ASKENAZI, DAVID JOSEPH, GOLDSTEIN, STUART L · 2014 to 2019
$3.0M
Developmental Origins of Cardiovascular Disease in Offspring from Non-Human Primate Pregnancies at Advanced Maternal AgeR01HL164434 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Sarah N Cilvik · 2023 to 2026
$3.0M
Preterm Epo Neuroprotection Trial (PENUT Trial) DCCU01NS077955 · NINDS · UNIVERSITY OF WASHINGTON · PI HEAGERTY, PATRICK J · 2013 to 2018
$1.5M
The role of angiotensin-(1-7) in hypertension and hypertension-induced heart and kidney damageK23HL148394 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SOUTH, ANDREW MICHAEL · 2020 to 2024
$783k
Resting state MRI to map autoregulation of the kidneyR21DK134104 · NIDDK · WASHINGTON UNIVERSITY · PI BENNETT, KEVIN M · 2022 to 2023
$679k
Machine Learning Risk Prediction of Kidney Disease After Extremely Preterm BirthK23DK131289 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SANDERSON, KEIA · 2023 to 2025
$602k
Bridging the gap of late gestation human nephrogenesis using a non-human primate modelK08DK131259 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI SCHUH, MEREDITH · 2022 to 2024
$574k
Translational imaging tools to nondestructively measure nephron massR41DK129138 · NIDDK · XN BIOTECHNOLOGIES, LLC · PI BENNETT, KEVIN M · 2021 to 2021
$300k
NCATS NIH HHS KL2 TR002737NHLBI NIH HHS K23 HL148394NHLBI NIH HHS L40 HL148910NHLBI NIH HHS R01 HL146818NHLBI NIH HHS R01 HL164434NIDDK NIH HHS K08 DK131259NIDDK NIH HHS K23 DK131289NIDDK NIH HHS L40 DK130155NIDDK NIH HHS P50 DK096373NIDDK NIH HHS R01 DK103608NIDDK NIH HHS R21 DK134104NIDDK NIH HHS R41 DK129138NIDDK NIH HHS R56 DK110622NINDS NIH HHS U01 NS077953NINDS NIH HHS U01 NS077955
6 · The paper itself

Abstract

backgroundWe evaluated time-varying perinatal risk factors associated with early (≤7 post-natal days) and late (>7 post-natal days) severe acute kidney injury (AKI) occurrence and duration.

methodsA secondary analysis of Preterm Erythropoietin Neuroprotection Trial data. We defined severe AKI (stage 2 or 3) per neonatal modified Kidney Disease: Improving Global Outcomes criteria. Adjusted Cox proportional hazards models were conducted with exposures occurring at least 72 h before severe AKI. Adjusted negative binomial regression models were completed to evaluate risk factors for severe AKI duration.

resultsOf 923 participants, 2% had early severe AKI. In the adjusted model, gestational diabetes (adjusted HR (aHR) 5.4, 95% CI 1.1-25.8), non-steroidal anti-inflammatory drugs (NSAIDs) (aHR 3.2, 95% CI 1.0-9.8), and vancomycin (aHR 13.9, 95% CI 2.3-45.1) were associated with early severe AKI. Late severe AKI occurred in 22% of participants. Early severe AKI (aHR 2.5, 95% CI 1.1-5.4), sepsis (aHR 2.5, 95% CI 1.4-4.4), vasopressors (aHR 2.9, 95% CI 1.8-4.6), and diuretics (aHR 2.6, 95% CI 1.9-3.6) were associated with late severe AKI. Participants who had necrotizing enterocolitis or received NSAIDs had longer severe AKI duration.

conclusionWe identified major risk factors for severe AKI that can be the focus of future research. IMPACT STATEMENT: Time-dependent risk factors for severe acute kidney injury (AKI) and its duration are not well defined among infants born <28 weeks' gestation. Over 1 in 5 infants born <28 weeks' gestation experienced severe AKI, and this study identified several major time-dependent perinatal risk factors occurring within 72 h prior to severe AKI. This study can support efforts to develop risk stratification and clinical decision support to help mitigate modifiable risk factors to reduce severe AKI occurrence and duration.

Indexed as

Acute Kidney InjuryInfant, Extremely PrematureAnti-Inflammatory Agents, Non-SteroidalDiabetes, GestationalFemaleGestational AgeHumansInfant, NewbornMalePregnancyProportional Hazards ModelsRisk FactorsSepsisSeverity of Illness IndexTime FactorsVancomycinAnti-Inflammatory Agents, Non-SteroidalVancomycin

Identifiers

PMID38438550
PMCPMC11371939
OpenAlexW4392362114

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.